Amedeo Smart

Free Medical Literature Service

 

Amedeo

Ischemic Heart Disease
  Free Subscription

Articles published in
Thromb Haemost
    April 2024
  1. KIM SH, Shin S, Choo EH, Choi IJ, et al
    Clinical impact of dyspnoea after ticagrelor treatment and the effect of switching to clopidogrel in patients with myocardial infarction.
    Thromb Haemost. 2024 Apr 4. doi: 10.1055/a-2299-4537.
    >> Share

    March 2024
  2. ORTEGA-PAZ L, Franchi F, Rollini F, Galli M, et al
    Switching from Dual Antiplatelet Therapy with Aspirin Plus a P2Y12 Inhibitor to Dual Pathway Inhibition with Aspirin Plus Vascular-Dose Rivaroxaban: The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) Study.
    Thromb Haemost. 2024;124:263-273.
    >> Share

    December 2023
  3. SUH JW, Memtsas V, Gue YX, Cho HW, et al
    Ethnic Differences in Thrombotic Profiles of Acute Coronary Syndrome Patients and Relationship to Cardiovascular Outcomes: A Comparison of East Asian and White subjects.
    Thromb Haemost. 2023 Dec 29. doi: 10.1055/s-0043-1777794.
    >> Share

  4. LI J, Chen R, Zhou J, Wang Y, et al
    Atherosclerotic Autoantigen ALDH4A1 as a Novel Immunological Indicator for Plaque Erosion in Patients with ST Segment Elevated Myocardial Infarction.
    Thromb Haemost. 2023 Dec 18. doi: 10.1055/s-0043-1777265.
    >> Share

  5. YE Y, Hao Y, Zhao X, Liu J, et al
    Percutaneous coronary intervention in acute coronary syndrome with mild-to-moderate thrombocytopenia.
    Thromb Haemost. 2023 Dec 11. doi: 10.1055/a-2225-5263.
    >> Share

    October 2023
  6. PEDERSEN OB, Hvas AM, Pasalic L, Kristensen SD, et al
    Platelet Function and Maturity and Related microRNA Expression in Whole Blood in Patients with ST-Segment Elevation Myocardial Infarction.
    Thromb Haemost. 2023 Oct 16. doi: 10.1055/s-0043-1776305.
    >> Share

    September 2023
  7. BONGIOVANNI D, Novelli L, Condello F, Kirmes K, et al
    Reticulated Platelets Predict Cardiovascular Death and Adverse Events in Coronary Artery Disease: A Systematic Review and Meta-analysis.
    Thromb Haemost. 2023 Sep 11. doi: 10.1055/s-0043-1773763.
    >> Share

  8. ESTEVE-PASTOR MA, Soler E, Marin F
    Reticulated platelets: a promising prognosis marker in cardiovascular diseases.
    Thromb Haemost. 2023 Sep 7. doi: 10.1055/a-2170-1892.
    >> Share

  9. VILELLA-FIGUEROLA A, Cordero A, Mirabet S, Munoz-Garcia N, et al
    Platelet-Released Extracellular Vesicle Characteristics Differ in Chronic and in Acute Heart Disease.
    Thromb Haemost. 2023;123:892-903.
    >> Share

    August 2023
  10. HE HM, Chen YN, Zeng JL, Zheng SW, et al
    The Prognostic Value of the Age-D-Dimer-Albumin Score in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
    Thromb Haemost. 2023 Aug 29. doi: 10.1055/s-0043-1773764.
    >> Share

  11. LAHU S, Adler K, Mayer K, Hein-Rothweiler R, et al
    Plasma Soluble Glycoprotein VI, Platelet Function, Bleeding, and Ischemic Events in Patients Undergoing Elective Percutaneous Coronary Intervention.
    Thromb Haemost. 2023 Aug 17. doi: 10.1055/s-0043-1772221.
    >> Share

  12. GOROG DA, Jeyalan V, Markides RIL, Navarese EP, et al
    Comparison of De-escalation of DAPT Intensity or Duration in East Asian and Western Patients with ACS Undergoing PCI: A Systematic Review and Meta-analysis.
    Thromb Haemost. 2023;123:773-792.
    >> Share

    July 2023
  13. WANG P, Yuan D, Zhao X, Zhu P, et al
    Inverse Association of Lipoprotein(a) on Long-Term Bleeding Risk in Patients with Coronary Heart Disease: Insight from a Multicenter Cohort in Asia.
    Thromb Haemost. 2023 Jul 24. doi: 10.1055/s-0043-1771188.
    >> Share

    June 2023
  14. HARM T, Frey M, Dittrich K, Goldschmied A, et al
    Statin Treatment Is Associated with Alterations in the Platelet Lipidome.
    Thromb Haemost. 2023;123:585-596.
    >> Share

  15. SONG H, Ahn JH, Kang MG, Kim KH, et al
    Post-PCI Risk Assessment by Inflammation Activity According to Disease Acuity and Time from Procedure.
    Thromb Haemost. 2023;123:627-640.
    >> Share

    May 2023
  16. GIANNIS D, Goldin M, Rahman H, Sison CP, et al
    Risk factors for post-discharge major thromboembolism and mortality in hospitalized patients with COVID-19 with cardiovascular comorbidities.
    Thromb Haemost. 2023 May 5. doi: 10.1055/a-2087-3003.
    >> Share

    April 2023
  17. CHEN D, Zhao Z, Liu P, Liu X, et al
    Adventitial Vasa Vasorum Neovascularization in Femoral Artery of Type 2 Diabetic Patients with Macroangiopathy Is Associated with Macrophages and Lymphocytes as well as the Occurrence of Cardiovascular Events.
    Thromb Haemost. 2023 Apr 10. doi: 10.1055/s-0043-1768162.
    >> Share

    March 2023
  18. LIU D, Zhang P, Zhang K, Bi C, et al
    Role of GPR56 in Platelet Activation and Arterial Thrombosis.
    Thromb Haemost. 2023;123:295-306.
    >> Share

    January 2023
  19. NICOLAJSEN CWW, Bronnum Nielsen P, Jensen M, Eldrup N, et al
    Stroke and myocardial infarction in patients with abdominal aortic aneurysms and new-onset atrial fibrillation.
    Thromb Haemost. 2023 Jan 10. doi: 10.1055/a-2009-8954.
    >> Share

  20. VERHEUGT FWA, Huber K
    Continuous Improvement of Antiplatelet Therapy in Cardiovascular Disease.
    Thromb Haemost. 2023 Jan 5. doi: 10.1055/s-0042-1760129.
    >> Share

  21. PEDERSEN OB, Grove EL, Nissen PH, Larsen SB, et al
    Expression of microRNA Predicts Cardiovascular Events in Patients with Stable Coronary Artery Disease.
    Thromb Haemost. 2023 Jan 5. doi: 10.1055/s-0042-1760258.
    >> Share

  22. ZHU W, Cao Y, Ye M, Huang H, et al
    Essen Stroke Risk Score Predicts Clinical Outcomes in Heart Failure Patients with Preserved Ejection Fraction: Evidence from the TOPCAT trial.
    Thromb Haemost. 2023;123:85-96.
    >> Share

    December 2022
  23. NILSEN DWT, Roysland M, Ueland T, Aukrust P, et al
    The Effect of Protease-Activated Receptor-1 (PAR-1) Inhibition on Endothelial-Related Biomarkers in Patients with Coronary Artery Disease.
    Thromb Haemost. 2022 Dec 31. doi: 10.1055/s-0042-1760256.
    >> Share

  24. VERHEUGT FWA, Huber K, Clemmensen P, Collet JP, et al
    Platelet P2Y12 Inhibitor Monotherapy after Percutaneous Coronary Intervention: An Emerging Option for Antiplatelet Therapy De-escalation.
    Thromb Haemost. 2022 Dec 30. doi: 10.1055/s-0042-1755330.
    >> Share

    November 2022
  25. KOCH T, Lahu S, Coughlan JJ, Cassese S, et al
    Association between Platelet Count and Treatment Effect of Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes.
    Thromb Haemost. 2022 Nov 28. doi: 10.1055/a-1988-5047.
    >> Share

  26. SHAO QY, Wang ZJ, Ma XT, Wang YF, et al
    Mortality of Escalation and Modulation Antithrombotic Therapy in Coronary Artery Disease Patients: A Meta-analysis of Randomized Controlled Trials.
    Thromb Haemost. 2022 Nov 7. doi: 10.1055/s-0042-1757405.
    >> Share

    October 2022
  27. BUCKLEY BJR, Lip GYH
    Current Concepts: Comprehensive "Cardiovascular Health" Rehabilitation-An Integrated Approach to Improve Secondary Prevention and Rehabilitation of Cardiovascular Diseases.
    Thromb Haemost. 2022 Oct 28. doi: 10.1055/s-0042-1757403.
    >> Share

  28. ROONGSANGMANOON W, Chichareon P, Angkananard T, Suwannasom P, et al
    External validation of ACUITY/HORIZON bleeding risk score among acute coronary syndrome patients in Thai PCI Registry.
    Thromb Haemost. 2022 Oct 20. doi: 10.1055/a-1964-8247.
    >> Share

    September 2022
  29. GUEANT JL, Gueant-Rodriguez RM, Oussalah A, Zuily S, et al
    Hyperhomocysteinemia in cardiovascular diseases: revisiting observational studies and clinical trials.
    Thromb Haemost. 2022 Sep 28. doi: 10.1055/a-1952-1946.
    >> Share

  30. RIKKEN SAOF, Storey RF, Andreotti F, Clemmensen P, et al
    Parenteral Antiplatelet Drugs in ST-Elevation Myocardial Infarction: Current Status and Future Directions.
    Thromb Haemost. 2022 Sep 8. doi: 10.1055/s-0042-1753479.
    >> Share

    August 2022
  31. BAMPATSIAS D, Mavroeidis I, Tual-Chalot S, Vlachogiannis NL, et al
    Beta-secretase-1 antisense RNA is associated with vascular ageing and atherosclerotic cardiovascular disease.
    Thromb Haemost. 2022 Aug 1. doi: 10.1055/a-1914-2094.
    >> Share

    June 2022
  32. NOUMEGNI SR, Mansourati V, Tromeur C, Mao RL, et al
    Risk Factors of Cardiovascular Death after Venous Thromboembolism: Results from a Prospective Cohort Study.
    Thromb Haemost. 2022 Jun 18. doi: 10.1055/s-0042-1748889.
    >> Share

  33. ARASHI H, Yamaguchi J, Hagiwara N, Yasuda S, et al
    Rivaroxaban Underdose for Atrial Fibrillation with Stable Coronary Disease: The AFIRE Trial Findings.
    Thromb Haemost. 2022 Jun 13. doi: 10.1055/s-0042-1744543.
    >> Share

  34. AKYEA RK, Georgiopoulos G, Iyen B, Kai J, et al
    Comparison of risk of serious cardiovascular events after haemorrhagic versus ischaemic stroke: a population-based study.
    Thromb Haemost. 2022 Jun 10. doi: 10.1055/a-1873-9092.
    >> Share

    May 2022
  35. TASOUDIS P, Kyriakoulis I, Sagris D, Diener HC, et al
    Clopidogrel monotherapy versus Aspirin monotherapy in patients with established cardiovascular disease: systematic review and meta-analysis.
    Thromb Haemost. 2022 May 16. doi: 10.1055/a-1853-2952.
    >> Share

  36. ZHANG Y, Zhang Y, Shi X, Lin B, et al
    Clopidogrel versus Ticagrelor in CYP2C19 Loss-of-Function Allele Noncarriers: A Real-World Study in China.
    Thromb Haemost. 2022;122:842-852.
    >> Share

    April 2022
  37. PATTI G, Grisafi L, Spinoni E, Rognoni A, et al
    Safety and efficacy of selective, clopidogrel-based strategies in acute coronary syndrome: a study-level meta-analysis.
    Thromb Haemost. 2022 Apr 18. doi: 10.1055/a-1827-8041.
    >> Share

    March 2022
  38. DEL BIANCO-RONDEAU M, Robert-Halabi M, Bloom S, Rabasa-Lhoret R, et al
    Aspirin for Primary Cardiovascular Prevention in Patients with Diabetes: Uncertainties and Opportunities.
    Thromb Haemost. 2022 Mar 4. doi: 10.1055/s-0042-1743469.
    >> Share

  39. MALY M, Riedel T, Stikarova J, Suttnar J, et al
    Incorporation of Fibrin, Platelets, and Red Blood Cells into a Coronary Thrombus in Time and Space.
    Thromb Haemost. 2022;122:434-444.
    >> Share

    February 2022
  40. LOPEZ-GALVEZ R, Rivera-Caravaca JM
    Growth differentiation factor 15 (GDF-15) in cardiovascular diseases: predicting bleeding after cardiac surgery and beyond that!
    Thromb Haemost. 2022 Feb 10. doi: 10.1055/a-1768-4206.
    >> Share

  41. NAVARESE EP, Grisafi L, Spinoni EG, Mennuni MG, et al
    Safety and Efficacy of Different Antithrombotic Strategies after Transcatheter Aortic Valve Implantation: A Network Meta-Analysis.
    Thromb Haemost. 2022;122:216-225.
    >> Share

    January 2022
  42. CLELAND JGF
    Aspirin for Primary and Secondary Prevention of Cardiovascular Disease: Time to Stop?
    Thromb Haemost. 2022 Jan 20. doi: 10.1055/s-0041-1740639.
    >> Share

  43. CANTONI S, Colombo C, Soriano F, Oreglia JA, et al
    RARE CAUSES OF ACUTE CORONARY SYNDROME: THE JAK2 V617F MUTATION POSITIVE MYELOPROLIFERATIVE NEOPLASMS. A cardio-hematological perspective.
    Thromb Haemost. 2022 Jan 17. doi: 10.1055/a-1742-0361.
    >> Share

  44. GOROG DA, Massberg S
    NETs in the infarct-related coronary artery - a marker or mediator of adverse outcome?
    Thromb Haemost. 2022 Jan 10. doi: 10.1055/a-1733-9217.
    >> Share

  45. CHAO TF, Joung B, Takahashi Y, Lim TW, et al
    2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary.
    Thromb Haemost. 2022;122:20-47.
    >> Share

    November 2021
  46. BLASCO A, Coronado MJ, Vela P, Martin P, et al
    Prognostic implications of Neutrophil Extracellular Traps in coronary thrombi of patients with ST-elevation myocardial infarction.
    Thromb Haemost. 2021 Nov 30. doi: 10.1055/a-1709-5271.
    >> Share

    October 2021
  47. BOJIC M, Bielesz B, Cejka D, Schernthaner GH, et al
    Calcification Propensity in Serum and Cardiovascular Outcome in Peripheral Artery Disease.
    Thromb Haemost. 2021 Oct 31. doi: 10.1055/s-0041-1736444.
    >> Share

  48. MCCUTCHEON K, Manga P
    Human Immunodeficiency Virus and Cardiovascular Disease: Revisiting the Inflammation-Thrombosis Axis.
    Thromb Haemost. 2021 Oct 24. doi: 10.1055/s-0041-1736445.
    >> Share

  49. CALDERONE D, Greco A, Ingala S, Agnello F, et al
    Efficacy and safety of aspirin for cardiovascular risk prevention in younger and older age: an updated systematic review and meta-analysis.
    Thromb Haemost. 2021 Oct 12. doi: 10.1055/a-1667-7427.
    >> Share

  50. JEONG YH, Oh JH, Yoon HJ, Park Y, et al
    Pharmacodynamic Profile and Prevalence of Bleeding Episode in East Asian Patients with Acute Coronary Syndromes Treated with Prasugrel Standard-Dose versus De-escalation Strategy: A Randomized A-MATCH Trial.
    Thromb Haemost. 2021;121:1376-1386.
    >> Share

    July 2021
  51. VERA A, Rivero F, Salamanca J, Alvarado-Casas T, et al
    Coronary Plaque Erosion after Abemaciclib Treatment Onset: An Unknown Side Effect?
    Thromb Haemost. 2021;121:976-978.
    >> Share

    February 2021
  52. YAMASHITA A, Nishihira K, Gi T, Maekawa K, et al
    Pathological Features of Ruptured Coronary Plaque and Thrombus Interfaces: Fibrin and von Willebrand Factor as Platelet Scaffolds on Rupture Sites.
    Thromb Haemost. 2021;121:234-241.
    >> Share

  53. VAN PARIDON PCS, Panova-Noeva M, van Oerle R, Schulz A, et al
    Relation between Tissue Factor Pathway Inhibitor Activity and Cardiovascular Risk Factors and Diseases in a Large Population Sample.
    Thromb Haemost. 2021;121:174-181.
    >> Share

    January 2021
  54. MANDROLA JM, Kaul S, Foy A
    Lessons Learnt from Recent Trials in Ischemic Heart Disease.
    Thromb Haemost. 2021;121:8-14.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016